The aforementioned markers (SYP, CGA, and INSM1) were evaluated with both pure primary pancreatic NET and mixed adenoneuroendocrine carcinoma (MiNEN, which contains both NET and carcinoma components). This evidence concerns the gene INSM1 and pancreatic neuroendocrine tumor.